An overview of the latest ASCO recommendations about antiemetic prophylaxis for treatment-related nausea and vomiting

Abstract

Nausea and vomiting (N&V) are among the most feared symptoms of cancer treatment. Since treatment-related N&V is predictable up to some extent, a systematic approach is recommended for prevention. Recently, ASCO has updated and released its' guideline for the prevention of treatment-related N&V. This paper is aimed to summarise the key changes and recommendations of ASCO for practicing medical or radiation oncologists treating adult cancer patients.

Keywords

• Palliative care
• Nausea
• Vomiting
• NK1 antagonists
• Olanzapine
• 5HT3 antagonist antiemetic prophylaxis